文献速递泌尿生殖与妇科肿瘤放疗放疗物理与技术

冷冻治疗失败后前列腺挽救性图像引导放疗

Salvage image guided radiation therapy to the prostate after cryotherapy failure.
PubMed 文献 · Adv Radiat Oncol · 2017-09-27

本研究回顾性分析了2005至2016年间8例冷冻治疗后生化失败的前列腺癌患者,接受剂量递增图像引导调强放疗(IG-IMRT)的疗效与毒性。中位总剂量77.7 Gy,中位随访55个月,6例保持生化控制,无≥2级急性胃肠道毒性及晚期泌尿生殖毒性,但样本量小需谨慎解读。

要点

  • 冷冻治疗后挽救性IG-IMRT中位剂量77.7 Gy,6/8例生化控制。
  • 无≥2级急性胃肠道毒性,无晚期胃肠道或泌尿生殖毒性。
  • 样本仅8例,结论需进一步研究验证。

核心结论

  • 高剂量IG-IMRT对冷冻治疗后局部复发前列腺癌有较高挽救率和极低严重晚期毒性。
  • 因样本量小,对冷冻治疗后挽救放疗仍需谨慎并进一步研究。

研究设计与样本

  • 回顾性研究,纳入2005至2016年在本机构接受冷冻治疗为初始治疗、后行挽救性IGRT的患者8例。
  • 放疗采用剂量递增IG-IMRT,后缘3 mm、其他方向7 mm标准边界,每日锥形束CT或kV影像引导至植入基准标记。

主要发现

  • 中位总剂量77.7 Gy(范围75.6-81.0 Gy),中位随访55个月(范围6-88个月)。
  • 6例在末次随访时保持生化控制,1例22个月后出现远处转移,1例30个月时生化失败但无远处转移证据。
  • 无患者出现≥2级急性胃肠道毒性,无晚期胃肠道或泌尿生殖毒性病例。

关键数值与推荐

  • 生化进展按Phoenix共识会议定义判定。

临床怎么用

  • 对冷冻治疗后局部复发的前列腺癌,可考虑剂量递增IG-IMRT作为挽救治疗选项。
  • 治疗时采用后缘3 mm、其他方向7 mm边界及每日影像引导至基准标记。

局限性

  • 样本量仅8例,作者指出本系列及其他系列患者数少,需谨慎对待并进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Cryotherapy is an option for the primary treatment of localized prostate cancer, along with radical prostatectomy, external beam radiation therapy, and brachytherapy. Although it is known that local recurrence can occur in >20% of patients treated with primary cryotherapy, unfortunately there is a paucity of data on later salvage treatments. The use of external beam radiation therapy is an attractive option after cryotherapy failure, but there is little data on its efficacy and toxicity. We evaluated the biochemical control and complication rates of salvage dose-escalated image guided intensity modulated radiation therapy (IG-IMRT) after cryotherapy failure. METHODS AND MATERIALS: Patients who were treated at our institution from 2005 to 2016 were reviewed for those who underwent cryotherapy as initial treatment followed by salvage IGRT. Patients were treated with dose-escalated IG-IMRT using standard treatment margins of 3 mm posterior and 7 mm in all other directions and daily cone beam computed tomography or kv imaging to implanted fiducial markers. Biochemical progression was defined in accordance with the Phoenix consensus conference definition. RESULTS: Eight patients were identified as having received post-cryotherapy salvage radiation within the study period. The median total dose was 77.7 Gy (range, 75.6-81.0 Gy). Median follow-up was 55 months (range, 6-88 months). Six patients remained biochemically controlled at the latest follow-up. One patient developed distant metastases after 22 months and one experienced biochemical failure at 30 months with no evidence of distant metastases. No patients experienced acute gastrointestinal toxicities of grade 2 or higher. There were no cases of late gastrointestinal or genitourinary toxicity. CONCLUSIONS: High-dose IG-IMRT results in high rates of salvage and extremely low rates of serious late toxicity for patients with locally recurrent prostate cancer after cryotherapy. Although the results are encouraging, given the small number of patients in this and other series, we remain cautious with regard to this treatment and believe the use of salvage radiation therapy after cryotherapy warrants further study.

来源:Adv Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Hopper AB, Sandhu APS, Parsons JK, et al. Salvage image guided radiation therapy to the prostate after cryotherapy failure. Adv Radiat Oncol. 2017. PMID: 29556580. doi:10.1016/j.adro.2017.09.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。